Literature DB >> 11592309

The relationship of BRMS1 and RhoGDI2 gene expression to metastatic potential in lineage related human bladder cancer cell lines.

M J Seraj1, M A Harding, J J Gildea, D R Welch, D Theodorescu.   

Abstract

We have recently characterized a human bladder cancer cell line T24 and a more aggressive lineage related variant of it, T24T. To gain further insights, we have studied their metastatic ability in an in vivo model system. Results show that T24 forms significantly fewer [4/12 (1/11) mice had metastases with 1-2 lesions/mouse] metastasis in SCID/bg mice than T24T [14/14 (6/6) mice had metastases with a mean of 24-28 lesions/mouse]. To begin exploring the mechanisms underlying this difference, we evaluated the mRNA and protein expression levels of metastasis-suppressor genes, known to be important in the progression of other cancers, in our model of bladder cancer progression. A higher mRNA expression of BRMS1, a metastasis suppressor in breast cancer, was observed in T24 cells. In addition, RhoGDI2 mRNA expression was only observed in T24 when compared to T24T, suggesting that Rho activation might play a significant role in the metastatic cascade. However, a basal level mRNA expression of KISS1, described as metastasis suppressor in melanoma and breast, was observed in both the lines and had slightly higher expression in T24T. No difference of Nm23-H1, KAI1, MKK4/SEK1 and E-Cadherin protein levels were noted between these two lines. In summary, it appears that the T24/T24T paired cell lines constitute a useful model for the study of human bladder cancer metastasis that will allow both the discovery and mechanistic evaluation of genes potentially involved in this process.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11592309     DOI: 10.1023/a:1011819621859

Source DB:  PubMed          Journal:  Clin Exp Metastasis        ISSN: 0262-0898            Impact factor:   5.150


  40 in total

1.  Frequent loss of heterozygosity on chromosome 10q in muscle-invasive transitional cell carcinomas of the bladder.

Authors:  D Cappellen; S Gil Diez de Medina; D Chopin; J P Thiery; F Radvanyi
Journal:  Oncogene       Date:  1997-06-26       Impact factor: 9.867

2.  p53, bcl-2 and retinoblastoma proteins as long-term prognostic markers in localized carcinoma of the prostate.

Authors:  D Theodorescu; S R Broder; J C Boyd; S E Mills; H F Frierson
Journal:  J Urol       Date:  1997-07       Impact factor: 7.450

3.  Suppression of human melanoma metastasis following introduction of chromosome 6 is independent of NME1 (Nm23).

Authors:  M E Miele; A De La Rosa; J H Lee; D J Hicks; J U Dennis; P S Steeg; D R Welch
Journal:  Clin Exp Metastasis       Date:  1997-05       Impact factor: 5.150

4.  Established cell line of urinary bladder carcinoma (T24) containing tumour-specific antigen.

Authors:  J Bubeník; M Baresová; V Viklický; J Jakoubková; H Sainerová; J Donner
Journal:  Int J Cancer       Date:  1973-05       Impact factor: 7.396

5.  Critical factors in the biology of human cancer metastasis.

Authors:  I J Fidler
Journal:  Am Surg       Date:  1995-12       Impact factor: 0.688

6.  Genomic analysis of metastasis reveals an essential role for RhoC.

Authors:  E A Clark; T R Golub; E S Lander; R O Hynes
Journal:  Nature       Date:  2000-08-03       Impact factor: 49.962

7.  Functional evidence for a novel human breast carcinoma metastasis suppressor, BRMS1, encoded at chromosome 11q13.

Authors:  M J Seraj; R S Samant; M F Verderame; D R Welch
Journal:  Cancer Res       Date:  2000-06-01       Impact factor: 12.701

Review 8.  Nm23 and tumour metastasis: basic and translational advances.

Authors:  J M Freije; N J MacDonald; P S Steeg
Journal:  Biochem Soc Symp       Date:  1998

9.  Bladder irrigation specimens assayed by fluorescence in situ hybridization to interphase nuclei.

Authors:  L L Wheeless; J E Reeder; R Han; M J O'Connell; I N Frank; A T Cockett; A H Hopman
Journal:  Cytometry       Date:  1994-12-01

10.  Loss of heterozygosity on chromosome 18q is associated with muscle-invasive transitional cell carcinoma of the bladder.

Authors:  S F Brewster; J C Gingell; S Browne; K W Brown
Journal:  Br J Cancer       Date:  1994-10       Impact factor: 7.640

View more
  56 in total

1.  MicroRNA-423 enhances the invasiveness of hepatocellular carcinoma via regulation of BRMS1.

Authors:  Xiangjun Sun; Mingchun Wang; Haiyan Liu; Jian Wang
Journal:  Am J Transl Res       Date:  2017-12-15       Impact factor: 4.060

2.  RhoGDIbeta lacking the N-terminal regulatory domain suppresses metastasis by promoting anoikis in v-src-transformed cells.

Authors:  Takahide Ota; Masayo Maeda; Shiho Sakita-Suto; Xinwen Zhou; Manabu Murakami; Tsutomu Takegami; Masaaki Tatsuka
Journal:  Clin Exp Metastasis       Date:  2006-11-17       Impact factor: 5.150

Review 3.  Unraveling the enigmatic complexities of BRMS1-mediated metastasis suppression.

Authors:  Douglas R Hurst; Danny R Welch
Journal:  FEBS Lett       Date:  2011-08-05       Impact factor: 4.124

4.  Association between clinical characteristics and expression abundance of RTKN gene in human bladder carcinoma tissues from Chinese patients.

Authors:  Jie Fan; Li-Jie Ma; Shu-Jie Xia; Long Yu; Qiang Fu; Chao-Qun Wu; Xing-Hua Huang; Jian-Ming Jiang; Xiao-Da Tang
Journal:  J Cancer Res Clin Oncol       Date:  2004-12-14       Impact factor: 4.553

5.  RhoGDI2 is associated with HGF-mediated tumor invasion through VEGF in stomach cancer.

Authors:  Sung Ae Koh; Min Kyoung Kim; Kyung Hee Lee; Sang Woon Kim; Jae-Ryong Kim
Journal:  Clin Exp Metastasis       Date:  2014-09-25       Impact factor: 5.150

6.  Upregulated MT1-MMP/TIMP-2 axis in the TSU-Pr1-B1/B2 model of metastatic progression in transitional cell carcinoma of the bladder.

Authors:  Christine L Chaffer; Bonnie Dopheide; Daniel R McCulloch; Allan B Lee; Jane M Moseley; Erik W Thompson; Elizabeth D Williams
Journal:  Clin Exp Metastasis       Date:  2005       Impact factor: 5.150

7.  Rho GDP dissociation inhibitor 2 suppresses metastasis via unconventional regulation of RhoGTPases.

Authors:  Konstadinos Moissoglu; Kevin S McRoberts; Jeremy A Meier; Dan Theodorescu; Martin A Schwartz
Journal:  Cancer Res       Date:  2009-03-10       Impact factor: 12.701

Review 8.  Metastasis suppressor genes.

Authors:  Jinchun Yan; Qin Yang; Qihong Huang
Journal:  Histol Histopathol       Date:  2013-03       Impact factor: 2.303

9.  Genomic signatures of breast cancer metastasis.

Authors:  V Urquidi; S Goodison
Journal:  Cytogenet Genome Res       Date:  2007       Impact factor: 1.636

10.  Cyclin-dependent kinase-mediated phosphorylation of breast cancer metastasis suppressor 1 (BRMS1) affects cell migration.

Authors:  Siti Nur Ain Roesley; Randy Suryadinata; Emma Morrish; Anthonius Ricardo Tan; Samah M A Issa; Jonathan S Oakhill; Ora Bernard; Danny R Welch; Boris Šarčević
Journal:  Cell Cycle       Date:  2016       Impact factor: 4.534

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.